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ABSTRACT African swine fever virus (ASFV) is a complex, cytoplasmic double-
stranded DNA (dsDNA) virus that is currently expanding throughout the world.
Currently, circulating virulent genotype II Armenia/07-like viruses cause fatal dis-
ease in pigs and wild boar, whereas attenuated strains induce infections with
various levels of chronic illness. Sensing cytosolic dsDNA, mainly by the key DNA
sensor cyclic GMP-AMP synthase (cGAS), leads to the synthesis of type I inter-
feron and involves signaling through STING, TBK1, and IRF3. After phosphoryla-
tion, STING translocates from the endoplasmic reticulum to the Golgi compartment
and to the perinuclear region, acting as an indispensable adaptor connecting the
cytosolic detection of DNA to the TBK1-IRF3 signaling pathway. We demonstrate
here that attenuated NH/P68, but not virulent Armenia/07, activates the cGAS-
STING-IRF3 cascade very early during infection, inducing STING phosphorylation
and trafficking through a mechanism involving cGAMP. Both TBK1 and IRF3 are
subsequently activated and, in response to this, a high level of beta interferon
(IFN-) was produced during NH/P68 infection; in contrast, Armenia/07 infection
generated IFN- levels below those of uninfected cells. Our results show that vir-
ulent Armenia/07 ASFV controls the cGAS-STING pathway, but these mechanisms
are not at play when porcine macrophages are infected with attenuated NH/P68
ASFV. These findings show for the first time the involvement of the cGAS-STING-
IRF3 route in ASFV infection, where IFN- production or inhibition was found after
infection by attenuated or virulent ASFV strains, respectively, thus reinforcing the
idea that ASFV virulence versus attenuation may be a phenomenon grounded in
ASFV-mediated innate immune modulation where the cGAS-STING pathway might
play an important role.
IMPORTANCE African swine fever, a devastating disease for domestic pigs and wild
boar, is currently spreading in Europe, Russia, and China, becoming a global threat
with huge economic and ecological consequences. One interesting aspect of ASFV
biology is the molecular mechanism leading to high virulence of some strains com-
pared to more attenuated strains, which produce subclinical infections. In this work,
we show that the presently circulating virulent Armenia/07 virus blocks the synthesis
of IFN-, a key mediator between the innate and adaptive immune response. Arme-
nia/07 inhibits the cGAS-STING pathway by impairing STING activation during infec-
tion. In contrast, the cGAS-STING pathway is efficiently activated during NH/P68 at-
tenuated strain infection, leading to the production of large amounts of IFN-. Our
results show for the first time the relationship between the cGAS-STING pathway
and ASFV virulence, contributing to uncover the molecular mechanisms of ASFV vir-
ulence and to the rational development of ASFV vaccines.
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Pathogen associated molecular patterns (PAMPs) are recognized by pattern recog-nition receptors, which activate signal transduction pathways in order to induce
innate immune responses such as type I interferon (IFN) production. Cytoplasmic
double-stranded DNA (dsDNA) acts like a potent PAMP, sensed by cyclic GMP-AMP
synthase (cGAS). cGAS detects cytoplasmic dsDNA and catalyzes the synthesis of
GMP-AMP cyclic dinucleotide (cGAMP) (1, 2). cGAMP acts as a second messenger and
binds to the stimulator of interferon genes protein (STING), which traffics from the
endoplasmic reticulum (ER) to the trans-Golgi network (TGN), where TANK-binding
kinase 1 (TBK1) is recruited and phosphorylated. This event allows the recruitment of
IRF3 that is subsequently phosphorylated by TBK1 and then translocates to the nucleus,
where it acts as a transcription factor for type I IFN- gene expression (2–4).
African swine fever virus (ASFV) causes a lethal disease, which poses important
economic consequences to the pig industry and to the ecosystems in affected countries
(5). Because there is no suitable vaccine, at present, the spread of ASFV is uncontrolled.
ASFV expansion started in 2007 in the Republic of Georgia, then reached Russia, Eastern
and Central Europe, and recently China (6), where more than 75 outbreaks have been
declared so far. ASFV, the only member of the Asfaviridae family (7), is an enveloped,
cytoplasmic dsDNA virus that encodes more than 150 proteins in infected macro-
phages, the natural target cell population (8), including proteins that have various roles
in virus-host interactions and in the modulation of the immune response (9–17).
However, the function of many viral gene products remains unknown (18).
In Africa, wild suidae, such as warthogs and bush pigs, are also infected with ASFV;
however, they show only subclinical infections and can act as virus carriers. In contrast,
acute ASF in domestic pigs or the European wild boar is characterized by hemorrhages
in lymph nodes and internal organs and high temperatures, resulting in the death of
the animal in about 7 to 10 days. Different strains of the virus exhibit different virulence,
ranging from peracute to acute to subclinical and chronic forms of the disease
(reviewed in reference 19). The fact that ASFV strains display different virulence
patterns, suggests a distinctive activation of the immune system (reviewed in reference
20), resulting in a complex scenario of virus-host interactions (21–23) and type I IFN
cascade (24).
Our studies show, for the first time, that virulent ASFV Armenia/07 strain has
acquired specific mechanisms to control IFN- production during infection of porcine
alveolar macrophages. These mechanisms involve the inhibition of (i) cGAS-dependent
viral DNA sensing, (ii) cGAMP-mediated phosphorylation of STING, (iii) STING trafficking,
and (iv) TBK1/IRF3 activation. The inhibition and control of IFN- synthesis, one of the
most important antiviral immune factors, is most likely an essential feature for the
virulent ASFV Armenia/07 strain. On the other hand, the induction of IFN- by NH/P68
could further explain its in vivo attenuation.
RESULTS
Virulent ASFV Armenia/07 infection inhibits mRNA production and secretion of
IFN-. ASFV strains can either cause chronic, subclinical, or fatal, acute ASF disease. In
order to study whether differences in ASFV virulence are related to differences in the
activation of the innate immune response, we analyzed the level of IFN- produced by
porcine alveolar macrophages infected either with NH/P68 (attenuated) or with Arme-
nia/07 (virulent) ASFV strains. For this purpose, a time course experiment in macro-
phages at 0, 4, 8, and 16 h postinfection (hpi) was performed. Figure 1A shows a higher
production of IFN- mRNA in cells infected with NH/P68 compared to those infected
with Armenia/07, starting at 4 hpi with a maximum at 16 hpi, a time point where IFN-
mRNA was very low in cells infected with Armenia/07. Interestingly, we observed a
significant increase of IFN- mRNA in cells infected with NH/P68 from 4 to 16 hpi,
indicating that cellular signaling leading to IFN- transcription is activated during the
course of the infection with the attenuated virus. Next, the amount of IFN- secreted
during attenuated versus virulent infections was determined. Supernatants from either
NH/P68- or Armenia/07-infected macrophages were collected, and IFN- levels were
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measured by enzyme-linked immunosorbent assay (ELISA) (Fig. 1B). The results show a
strong decrease of secreted IFN- at 16 hpi, after an initial increase at 8 hpi, during the
infection with the virulent strain, whereas in NH/P68-infected macrophages the amount
of IFN- increases over time. These data correlate well with the results obtained
regarding IFN- mRNA production (Fig. 1A). This indicates that virulent ASFV shuts
down the IFN- synthesis pathway several hours after infection (Fig. 1A), although
IFN- mRNA production is significantly above the control level at 4 hpi. This effect also
translates to IFN- cytokine production, which initially increases and is totally abolished
at 16 hpi, when macrophages are infected with virulent ASFV (Fig. 1B).
In addition, we analyzed the expression of IFIT-1 and CXCL10, two IFN--dependent
genes (25, 26) at 0, 4, 8, and 16 hpi. Fig. 1C and D, show that Armenia/07 does not
activate either IFIT-1 or CXCL10 mRNA synthesis during the course of the infection,
whereas, in contrast, IFIT-1 and CXCL10 mRNA level increases during NH/P68 infection.
Finally, and as shown in Fig. 1E and F, the p32 mRNA and protein levels were equivalent
during the infection with both attenuated and virulent strains, thus demonstrating that
same amount of viruses have been used.
Taking together, these results reveal two important aspects regarding IFN- pro-
duction by attenuated versus virulent ASFV strains. First, the attenuated NH/P68 virus
induces the production of IFN- in infected macrophages, which in turn stimulates the
expression of IFN--dependent genes such as IFIT-1 and CXCL10. Second, the virulent
Armenia/07 strain is able to efficiently block IFN- mRNA synthesis and production in
infected macrophages.
The STING pathway is blocked by virulent Armenia/07, while it is activated by
attenuated NH/P68. Given the results described above, we set out to dissect the
molecular mechanism of IFN- inhibition/induction by different ASFV strains in infected
porcine alveolar macrophages.
It has been shown that induction of IFN- synthesis depends mainly on the
cGAS-STING pathway, which is triggered by the sensing of dsDNA in the cytoplasm (3).
We therefore studied the correlation between IFN- production and cGAS-STING
pathway activation in macrophages after infection with attenuated or virulent ASFV.
FIG 1 IFN-, IFIT-1, and CXCL10 expression in porcine alveolar macrophages infected by ASFV NH/P68 or Armenia/07 strains. Porcine alveolar macrophages
were mock infected or infected with NH/P68 or Armenia/07 strain (4 PFU/cell). Cells were collected at 4, 8, or 16 hpi. qPCR analyses of IFN- (A), IFIT-1 (C), and
CXCL10 (D) and of ASFV viral protein p32 (E) mRNAs were performed. (B) Supernatants were collected at 4, 8, or 16 hpi, and the concentration of IFN- was
determined by ELISA. (F) Cells were lysed in RIPA buffer at 4, 8, and 16 hpi, and lysates were separated by 7 to 20% SDS-PAGE, followed by immunoblotting
with anti-ASFV p32 (viral early p32) and anti-actin antibodies. The data are means  the standard errors of the mean (SEM; n 3). Data were statistically
analyzed by using a Student t test (*, P 0.05; **, P 0.01; ***, P 0.001).
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As seen in Fig. 2A, infection with NH/P68, but not with Armenia/07, induces
phosphorylation of STING and IRF3 at 16 hpi, indicating that the STING pathway is
activated in response to the infection with the attenuated, but not with the virulent,
ASFV strain. STING phosphorylation occurs as early as 1 hpi, reaches a peak at 2 to 4 hpi
and decreases by 16 hpi during NH/P68 infection (Fig. 2B). Meanwhile, IRF3 phosphor-
ylation, which controls IFN- transcription (2), starts at 4 hpi and increases until 16 hpi
(Fig. 2B). These data indicate that STING activation occurs early after NH/P68 infection
and before IRF3 phosphorylation and is maintained throughout 16 h of infection; this
supports the IFN- production data presented in Fig. 1.
In contrast, infection of macrophages with Armenia/07 produces only a weak
phosphorylation signal of STING after 2 and 4 hpi, which decreases at later time points
and is almost negative at 16 hpi (Fig. 2C). A similar activation profile was seen for IRF3
(Fig. 2C).
This demonstrates that—after initial moderate activation—virulent Armenia/07 is
able to inhibit STING and IRF3 phosphorylation at later time points after infection;
similar results were observed in regard to IFN- synthesis (Fig. 1B).
The specific inhibitor of cGAS, Ru521, inhibits the activation of STINGmediated
by NH/P68 and Armenia/07 infection. cGAS is a cellular sensor for cytoplasmic dsDNA
detection, which further induces STING pathway activation (27–29). To test the role of
cGAS in sensing of ASFV dsDNA, porcine alveolar macrophages were mock treated or
treated with increasing concentrations of the specific cGAS inhibitor Ru521 (30) for
30 min. Cells were then mock infected or infected with NH/P68 and Armenia/07 at a
multiplicity of infection (MOI) of 2 for 5 h or 2 h, a time by which pSTING was shown
to be maximum for attenuated and virulent strains, respectively (Fig. 2B and C). The
cells were then collected, and the STING phosphorylation level was analyzed by
Western blotting.
As Fig. 3 shows, STING phosphorylation was not detected in mock-infected cells,
independent of Ru521 treatment. As expected by this time of infection, during both
NH/P68 and Armenia/07 infections STING was phosphorylated in the nontreated cells;
however, interestingly, the level of STING phosphorylation decreased when Ru521 at
FIG 2 Effect of NH/P68 and Armenia/07 infection on STING and IRF3 phosphorylation. Porcine alveolar macrophages were mock infected or infected with
NH/P68 or Armenia/07 strains (2 PFU/cell). Cells were lysed in RIPA buffer at 16 hpi (A) or at 0, 1, 2, 4, 6, 8, and 16 hpi with NH/P68 (B) or Armenia/07 (C), and
lysates were separated by 7 to 20% SDS-PAGE, followed by immunoblotting with anti-p-STING, anti-STING, anti-p-IRF3, anti-IRF3, anti-ASFV p32 (viral early p32),
and anti-actin antibodies. Graphs below the panels B and C indicate the relative phosphorylated-STING versus total STING protein. Densitometry was performed
using ImageJ.
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concentrations of 20 and 50 g/ml was added at the beginning of the infection. These
results indicate the involvement of cGAS in the activation of the STING pathway
triggered, at early times after infection, either by NH/P68 or Armenia/07 ASFV strains.
Infection of NH/P68 phosphorylates IRF3 and induces its binding to chromatin.
As mentioned above, we have observed that infection with NH/P68 is able to substan-
tially activate the cGAS-STING pathway. It has been described previously that the
activation of STING and TBK1 induces the phosphorylation and then translocation of
phosphorylated IRF3 (p-IRF3) to the nucleus (31, 32), where it acts as a transcription
factor for IFN-. In order to analyze the phosphorylation status and cellular localization
of IRF3 during attenuated versus virulent ASFV infections, we used a specific antibody
to detect p-IRF3 in different subcellular locations of the cell. To achieve this, mock-
infected, NH/P68-infected, or Armenia/07-infected macrophages were fractionated af-
ter 8 hpi, a time point when both STING and IRF3 were found to be phosphorylated by
NH/P68 but not by Armenia/07 (Fig. 2B and C). Cytoplasmic (S2) and nuclear (P1)
fractions were obtained from the respective whole-cell extracts (WCE). Next, the P1
fraction was further separated into nuclear soluble fraction (S3) and chromatin fraction
(P3) (Fig. 4A). We used specific markers for each cell fraction to confirm the accuracy of
FIG 3 The activation of STING by NH/P68 and Armenia/07 is dependent on the cGAS sensor. Porcine alveolar
macrophages were untreated or treated with 1, 10, 20, or 50 g/ml of Ru521 and mock infected or infected with
NH/P68 or Armenia/07 (2 PFU/cell). At 2 or 5 h after Armenia/07 or NH/P68 infection, respectively, the cells were
lysed in RIPA buffer, and lysates were separated by 7 to 20% SDS-PAGE, followed by immunoblotting with
anti-p-STING, anti-STING, or anti-actin antibodies as a control. Numbers below the bands indicate the relative level
of phosphorylated STING. Densitometry was performed using ImageJ.
FIG 4 The activation of cGAS-STING by the attenuated strain NH/P68 promotes the translocation to the
nucleus of p-IRF3. (A) Scheme of the biochemical fractionation method. See Materials and Methods for
details. (B) Porcine alveolar macrophages were mock infected or infected with NH/P68 or Armenia/07
strain (2 PFU/cell). At 8 hpi the cells were collected, and chromatin fractionation was performed. The
WCE, cytoplasmic fraction (S2), chromatin fraction (P3), and soluble nuclear fraction (S3) were separated
by 7 to 20% SDS-PAGE, followed by immunoblotting with anti-p-IRF3, anti-1-laminin, anti-H3 (histone
3), anti-ASFV p32 (viral early p32), and anti-actin antibodies.
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the fractionating procedure: actin for the soluble fraction, histone 3 (H3) for the soluble
nuclear fraction, and 1-laminin for the chromatin fraction.
As shown in Fig. 4B and p-IRF3 is found in WCE from NH/P68 infected cells, whereas
it was not found in mock-infected cells or only in small amounts in Armenia/07-infected
cells. After cell fractionation, p-IRF3 is mainly detected in the cytoplasmic fraction of
alveolar macrophages infected with NH/P68, as well as in the soluble nuclear fraction
(S3) (Fig. 4C). p-IRF3 was also detected in the chromatin fraction (P3) of NH/P68-infected
cells, suggesting that at 8 h after NH/P68 infection, functional p-IRF3 binds to chroma-
tin, possibly acting as transcription factor for IFN-.
Only weak or no bands corresponding to p-IRF3 were detected either in the
chromatin fraction (P3) or in the nuclear soluble fraction (S3) in uninfected cells or in
cells infected with Armenia/07. These data suggest that the cGAS-STING pathway is
strongly activated during NH/P68 infection, resulting in the activation and translocation
of p-IRF3 to the nuclear chromatin fraction, where it activates synthesis of IFN-. In
contrast, ASFV Armenia/07 displays mechanisms which almost completely inhibit
p-IRF3 activation and translocation to the nucleus; this resulted in weak or no induction
of IFN- synthesis.
Armenia/07-induced blockage of the cGAS-STING pathway happens early dur-
ing viral infection. ASFV displays a very accurate temporal kinetics of replication in the
infected cell, producing early-early, early-late, and late viral mRNAs. These differently
timed messenger RNAs are the products of viral genes whose transcription is regulated
before or after viral DNA replication (8). In order to determine at what step of the
Armenia/07 replication the cGAS-STING route is blocked, we used cytosine arabinoside
(AraC), an inhibitor of viral DNA replication, widely used to prevent the expression of
late ASFV genes (8). In order to determine whether the cGAS-STING inhibition produced
by Armenia/07 occurs at early or late times of ASFV replication, we infected alveolar
macrophages in the presence or absence of AraC and analyzed the phosphorylation of
both STING and IRF3. The results showed that the cGAS-STING pathway inhibition by
Armenia/07 occurs at a time point prior to the replication of viral DNA. No phosphor-
ylation of STING and IRF3 was observed in the presence of AraC (Fig. 5), indicating that
early viral genes and/or gene products are involved in this inhibition exerted by the
virulent ASFV strain.
As a control for both the infection and the effects of AraC on viral DNA replication,
we employed a specific antibody to assess the expression of the viral protein p12, a late
viral product, which should be only expressed in the absence of AraC. As shown in the
Fig. 5, p12 is only found in the lanes corresponding to infected cells in the absence of
AraC.
FIG 5 The blocking of the cGAS-STING pathway mediated by Armenia/07 depends on the products of
viral early gene(s). Porcine alveolar macrophages were mock infected or infected with NH/P68 or
Armenia/07 strain (2 PFU/cell) and untreated or treated with 40 g/ml of cytosine arabinoside (AraC). At
16 h postinfection, the cells were lysed in RIPA buffer, and lysates were separated by 7 to 20% SDS-PAGE,
followed by immunoblotting with anti-p-STING, anti-STING, anti-p-IRF3, anti-IRF3, anti-1262, and anti-
actin antibodies, respectively.
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In contrast, NH/P68 infection induces activation of the cGAS-STING route in the
presence and absence of AraC, since phosphorylation of both STING and IRF3 are
observed. This indicates that the replication of NH/P68 viral DNA is not necessary to
activate the cGAS-STING pathway.
Armenia/07 blocks STING and TBK1 phosphorylation by a cGAMP-dependent
mechanism. Immediately after sensing cytoplasmic dsDNA, cGAS is activated to syn-
thesize cGAMP from ATP/GTP; cGAMP binds STING, inducing its phosphorylation,
dimerization, and activation (2). In order to analyze the mechanism that Armenia/07
uses to block STING phosphorylation and to determine whether cGAMP is involved, we
infected macrophages with increasing MOIs of Armenia/07 (Fig. 6A). At 5 hpi, a time
point by which Armenia/07 fully inhibits STING phosphorylation (see Fig. 2C), cGAMP
(10 g/ml) was added to the cultures. After an two additional hours of incubation (7
hpi), the phosphorylation of both STING and TBK1 was analyzed by Western blotting.
As shown in Fig. 6A, treatment of the noninfected cells with cGAMP induces
phosphorylation of STING and TBK1. In the presence of cGAMP, a decrease in the
amounts of both p-STING and p-TBK1 was observed when cells were infected with
Armenia/07 at an MOI of 8; this indicates that the virulent virus is able to reverse the
STING and TBK1 activation induced by cGAMP in a dose-dependent manner, probably
also involving a c-GAS-dependent mechanism. This result also shows that the viral
process to inhibit STING/TBK1 activation can be overcome by cGAMP, suggesting that
cGAMP is a critical component of the activation pathway. A specific monoclonal
antibody against the ASFV protein p32 was used as a control for ASFV infection of the
cells.
In an additional experiment, cGAMP (10 g/ml) was added after 14 h of infection
with the attenuated or the virulent ASFV strains and then incubated for two additional
hours with or without AraC (Fig. 6B). Exogenous cGAMP caused the phosphorylation of
STING in noninfected cells, which is also observed during NH/P68 infection. Interest-
ingly, the inhibition of STING phosphorylation induced by Armenia/07 (Fig. 2C and 5)
was reversed by exogenous cGAMP, confirming that Armenia/07 inhibits STING phos-
phorylation by a mechanism that involves cGAMP. To assess whether these events are
dependent on viral DNA replication, cells were treated with 40 g/ml of AraC. There
was no difference whether the cells were treated or not with AraC, suggesting that both
the STING blockage by Armenia/07 and the rescue by cGAMP are mechanisms inde-
pendent of viral replication, suggesting in turn that very early or early viral factors are
involved.
STING localizes at perinuclear microsomes in cells infected with NH/P68 but
not in cells infected with Armenia/07. As mentioned above, Armenia/07 blocks the
FIG 6 Armenia/07 blocks the phosphorylation of STING and TBK1 mediated by cGAMP. (A) Porcine
alveolar macrophages were mock infected or infected with Armenia/07 strain with 2, 4, or 8 PFU/cell. At
5 hpi, the cells were untreated or treated with 10 g/ml of cGAMP. At 2 h after cGAMP treatment, the
cells were collected. Numbers below the bands indicate the relative levels of p32 viral protein. Densi-
tometry was performed using ImageJ. (B) Porcine alveolar macrophages were mock infected or infected
with NH/P68 or Armenia/07 strain (2 PFU/cell) and untreated or treated with 40 g/ml of cytosine
arabinoside (AraC). At 14 hpi, the cells were untreated or treated with 10 g/ml of cGAMP. At 2 h after
cGAMP treatment, the cells were collected. (A and B) Cells were lysed in RIPA buffer, and lysates were
separated by 7 to 20% SDS-PAGE, followed by immunoblotting with anti-p-STING, anti-p-TBK1, anti-ASFV
p32 (viral early p32 protein), and anti-actin antibodies.
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cGAS-STING pathway by using early viral effectors downstream of cGAS activation.
STING activation requires posttranslational modifications, dimerization, and transport
from the ER through the Golgi to perinuclear structures, which are critical for its
function (33).
To investigate the localization of STING during ASFV infection, porcine alveolar
macrophages were mock infected or infected at an MOI of 2 for 6 h with Armenia/07
or NH/P68. cGAMP-treated macrophages were used as a positive control of STING
activation (20 g/ml), and the samples were then processed for immunofluorescence
by using a specific anti-STING antibody. As observed in Fig. 7A, cGAMP-treated cells and
cells infected with NH/P68 show STING localization in punctuate perinuclear structures
(or microsomes; highlighted by arrows). STING localization in microsomes indicates its
activation and has been described as necessary for further activation of downstream
components of the STING pathway (34). In contrast, cells infected with Armenia/07
present a more diffuse STING distribution pattern throughout the cytoplasm, similar to
that found in mock-infected cells. The latter results indicate a nonactivation status of
STING and confirms the small amount of p-STING we found during Armenia/07 infec-
tion (Fig. 2C). Both Armenia/07 and NH/P68 infections were confirmed by the presence
of viral factories, which are stained by DAPI (4=,6=-diamidino-2-phenylindole) as small
DNA accumulations next to the cell nucleus (arrowheads). We quantified STING distri-
bution pattern in infected cells, which were identified by the presence of viral factories.
This analysis revealed that in more than 80% of NH/P68-infected cells STING is localized
in punctuated perinuclear microsome structures (Fig. 7B). In contrast, STING was
localized in microsomes in less than 40% of Armenia/07-infected cells (Fig. 7B).
Taken together, these results indicate that Armenia/07 induces a blockage in the
activation and intracellular transport of STING, whereas NH/P68 infection does not,
resulting in a typical punctuate pattern surrounding the nucleus characteristic of STING
activation.
Differences in STING trafficking during NH/P68 versus Armenia/07 infection.
STING undergoes posttranslational modifications necessary for its activation during its
traffic through the Golgi network. In particular, during the passage through the
trans-Golgi network (TGN), activated STING induces TBK1 activation, which is a key
component in the pathway to activate IFN- production (34). Taking into account the
inhibition found on STING trafficking mediated by virulent Armenia/07 (Fig. 7), we
further assessed the impact that virulent strain exerts on the cellular transit of STING.
We hypothesized that the activation of STING, and therefore its traffic through the
TGN, should be an event occurring at early times after infection, since we have found
STING phosphorylation in the presence of AraC. Thus, we compared STING distribution
either at “very early” (1 hpi) or at “early” (6 hpi) times after infection with attenuated or
virulent ASFV strains. To do this, we used either NH/P68 or Armenia/07 at an MOI of 2
to infect porcine alveolar macrophages, together with cGAMP-treated macrophages as
a positive control of STING activation; the cells were then processed for immunofluo-
rescence, and specific antibodies against STING and against the AP1 complex (marker
for TGN [16, 35]) were applied. As shown in Fig. 8 (central panels), STING colocalizes
with AP1 (arrows) in both NH/P68- and Armenia/07-infected cells after 1 h of infection.
A similar colocalization pattern between STING and AP1 was found in cGAMP-treated
macrophages (Fig. 8). This indicates that both attenuated and virulent ASFV strains
“activate” STING trafficking very early after infection. By 6 hpi, STING accumulates in
punctuated perinuclear structures in cells infected with NH/P68 but not with Arme-
nia/07 (see Fig. 8, lower panels). Furthermore, STING partially colocalizes with AP1 in
cytoplasmic structures outside from perinuclear structures in NH/P68-infected cells.
Importantly, this colocalization pattern was not detected in cells infected with Arme-
nia/07 (Fig. 8, lower panels). AP1 is located mainly around the ASFV viral factories
(arrowhead) in both Armenia/07- and NH/P68-infected cells, a localization that was
previously described (16).
The degree of colocalization pattern observed under these conditions (Fig. 9A) was
quantified to determine the fraction of STING overlapping AP1 (Mander’s coefficient).
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As shown in Fig. 9B, the highest colocalization between STING and AP1 was found in
both NH/P68- and Armenia/07-infected cells after 1 h of infection, similarly to cGAMP-
treated cells. This colocalization degree strongly increases if quantification is restricted
to cells where STING is activated, forming punctuate structures (Fig. 9A, see arrows, and
Fig. 9C). These data emphasize that STING activates and traffics through the TGN during
both Armenia/07 and NH/P68 infection at the very early time of 1 hpi. However, the
STING-AP1 colocalization significantly decreased at 6 hpi and more specifically in
Armenia/07- versus NH/P68-infected cells, as shown in Fig. 9B and C.
FIG 7 STING locates at perinuclear clusters in porcine alveolar macrophages during NH/P68 but not during
Armenia/07 infection. (A) Porcine alveolar macrophages were mock infected or infected with NH/P68 or Arme-
nia/07 (5 PFU/cell) or treated with cGAMP (20 g/ml). At 6 hpi or 1 h after cGAMP treatment, the cells were fixed
and stained with DAPI and anti-STING antibody and then examined by using a confocal microscope. Arrows
indicate punctuated perinuclear structures. An arrowhead indicates viral factories. (B) Quantitative analysis of cells
with punctate pattern or diffused signal is presented. The percentage of cell number was calculated among 75 cells
under each condition.
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Altogether, these results suggest that whereas both virulent and attenuated ASFV
strains trigger the cGAS-STING pathway at very early times postinfection, Armenia/07 is
able to inhibit STING activation during later times of infection, thus impairing its
activation and traffic to perinuclear microsomes.
DISCUSSION
The manner how two different ASFV strains ranging in virulence affect IFN-
production of infected cells through the control of the cGAS-STING pathway has been
addressed in detail in the present study. One ASFV strain is NH/P68, a nonfatal, naturally
occurring, nonhaemadsorbing virus, isolated from a chronically infected pig (36), and
FIG 8 Differences on STING movement through the TGN during very early or early NH/P68 and Armenia/07
infections. Porcine alveolar macrophages were mock infected or infected with NH/P68 or Armenia/07 strain (2
PFU/cell) or treated with cGAMP (20 g/ml). At 1 and 6 hpi or 1 h after cGAMP-treatment, the cells were fixed and
stained with DAPI, anti-STING, and anti-AP1 antibodies and then examined by using a confocal microscope. An
arrowhead indicates viral factories. Arrows indicate colocalization between STING accumulations and AP1.
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FIG 9 Quantification of STING colocalization with AP1 at very early or early time points after NH/P68 and Armenia/07 infections. (A) Porcine alveolar
macrophages were mock infected or infected with NH/P68 or Armenia/07 strain (2 PFU/cell) or treated with cGAMP (20 g/ml). At 1 and 6 hpi or 1 h
after cGAMP treatment, the cells were fixed and stained with DAPI (blue), anti-STING (green), and anti-AP1 (red) antibodies and examined by using a
confocal microscope. Cells where STING exhibit a punctuate pattern are highlighted (arrows). (B and C) Quantification of fraction of STING overlapping
AP1 (Mander’s coefficient) for each condition (B) and only for cells with a STING punctuated pattern (arrows) at 1 hpi and cGAMP-treated cells (C). The
data are means  the SD (n 50). Data were statistically analyzed by using a Student t test (*, P 0.05; **, P 0.01; ***, P 0.001).
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the other ASFV strain is Armenia/07, a highly virulent virus currently circulating in
Europe, Russia, and China (37). Our results demonstrate that whereas Armenia/07
inhibits the synthesis of IFN- (and its dependent genes IFIT-1 and CXCL10) by
inhibiting IRF3 activation and STING phosphorylation, NH/P68 does not. Infection of
porcine alveolar macrophages with NH/P68 results in (i) the induction of significant
levels of IFN-, (ii) phosphorylation of STING, (iii) traffic of STING through the Golgi to
perinuclear punctuated structures, and (iv) localization of IRF3 to the nuclear soluble
fraction and binding to chromatin. Furthermore, inhibition of cGAS by the specific
inhibitor Ru521 (30) impairs NH/P68-induced STING phosphorylation, suggesting that
cGAS is the main DNA sensor activating the STING cascade by the attenuated ASFV
NH/P68 isolate. In contrast, cGAMP-induced phosphorylation of STING was prevented
by infection of cells with Armenia/07. Also, STING trafficking to perinuclear punctuated
structures was severely impaired in Armenia/07-infected cells, indicating that the
virulent ASFV strain prevents the activation and trafficking of STING.
Differences in the IFN-mRNA expression levels in infected cells have been reported
for other virulent and attenuated ASFV strains (38). Similar observations were made in
previous reports describing the inhibition of IFN- production during virulent ASFV
strain infection (39, 40). In contrast, Portugal et al. reported recently that IFN-
inhibition was exerted by both virulent and attenuated ASFV strains (41). Similarly,
when IFN- and IFN- were analyzed in sera from animals infected with virulent ASFV
strains (42, 43), induction of IFN- and IFN- was observed, which was attributed to
cytokine production by non-ASFV-susceptible cells. Since there are most likely several
pathways and virulence factors involved in ASFV virulence, this result is not surprising.
It is noteworthy that whereas our data show a strong inhibition of IFIT-1 mRNA
expression during Armenia/07 infection, in comparison with the expression during
NH/P68 infection, the amount of IFN- secreted after 8 hpi with Armenia/07 does not
affect IFN--dependent gene IFIT-1 expression. One possible explanation would be that
virulent strain may encode genes functionally homologous to type I IFN receptors as
has been described for vaccinia and other poxvirus (44), in such a way that the
produced IFN is “neutralized” at this time point of the virulent infection (8 hpi),
impairing the activation of IFN-dependent genes.
The cGAS-STING pathway, which leads to the production of IFN-, is critical for the
innate immune response and is therefore targeted by several viruses (45). Here, we
show for the first time that IFN- production during ASFV infection is controlled via the
cGAS-STING pathway. Importantly, early after infection the cGAS-STING pathway was
induced by both attenuated and virulent ASFV, but later on, was effectively inhibited
only by virulent Armenia/07. Our data reveal a clear correlation between ASFV virulence
and virus ability to inhibit the cGAS-STING pathway. Similar results have been obtained
with vaccinia virus, an ASFV-related, dsDNA cytoplasmic virus. The attenuated modified
vaccinia virus Ankara (MVA) induces IFN- in infected cells via the activation of the
cGAS-STING pathway (46), while virulent vaccinia strains prevent cGAS-STING activation
and hence IFN- production in infected cells (47). Our results, therefore, reinforce the
idea that ASFV virulence versus attenuation, two concepts controversially discussed in
the ASFV field, may be phenomena associated with the control of the cGAS-STING
pathway.
Activation of the cGAS-STING pathway involves the phosphorylation and transloca-
tion of STING from the ER through the Golgi compartment, the phosphorylation of both
TBK1 and IRF3, and the subsequent translocation of p-IRF3 to the nucleus. Using the
viral DNA replication inhibitor AraC, we showed that STING phosphorylation is impaired
by Armenia/07 in the presence of AraC, thus involving events happening before viral
DNA replication. In contrast, STING phosphorylation is triggered as early as 1 h after
NH/P68 infection and leads to the phosphorylation of IRF3, a transcription factor
regulating IFN- synthesis (31). The different time points at which IRF3 is phosphory-
lated during attenuated versus virulent strains suggest that a faster transition between
activated STING and phosphorylated IRF3 occurs during virulent strain infection. Phos-
phorylated IRF3 then translocates to the nucleus and binds to the chromatin fraction to
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induce IFN- production. The latter happens during NH/P68 infection, whereas during
Armenia/07 infection, IRF3 was not phosphorylated and consequently absent from the
nuclear and chromatin fractions of the infected cells. Interestingly, it has been recently
reported (48) that STING phosphorylation is required to further activate IRF3.
Similarly, STING activation and p-IRF3 have been found in the nuclear fraction in
cells infected with influenza virus (49) and the gammaherpesvirus rhesus rhadinovirus
(50), which are both able to induce IFN-. Furthermore, during MVA versus virulent
poxvirus WR infection, an opposing regulation of the IFN- has been reported. The
authors showed that attenuated MVA virus induced activation of the cGAS-STING
pathway, whereas inhibition of this pathway was observed during virulent WR infection
(46, 47); this behavior is similar to what we report here in relation to the regulation of
the cGAS-STING pathway by NH/P68 and Armenia/07 in infected cells.
STING is a prototype downstream effector, which can be modulated by several viral
products in order to counteract the cGAS-STING pathway and type I IFN production
(51–57). Activation of STING during viral infection can occur through the triggering of
different cytoplasmic dsDNA sensors (58–60). cGAS was identified as the main sensor of
this pathway in both humans and mice (27–29), playing an important role in type I IFN
response against DNA viruses, including HSV-1, KSHV, and vaccinia virus (2, 46, 56).
Importantly, we have been able to identify cGAS as the main DNA sensor involved in
STING activation upon ASFV infection in porcine alveolar macrophages. In fact, we
found that a specific inhibitor of cGAS, Ru521 (30), blocked the activation of STING
produced by NH/P68 infection. However, we cannot exclude the involvement of other
sensors such as IFI16 or sensors triggered in the absence of active cGAS (61, 62).
In addition, we showed that cGAMP, the cGAS-activated product mediating the
activation of STING, was counteracted during Armenia/07 but not NH/P68 infection,
suggesting that the viral mechanism displayed by Armenia/07 to inhibit STING activa-
tion somehow competes with cGAMP. It has been described that various viruses can act
at different levels to counteract the IFN- activation pathway (45). Here, we show that
virulent Armenia/07 is able to counteract cGAMP-dependent STING activation, even in
the presence of exogenous cGAMP. However, alternative inhibition modes exerted by
Armenia/07 or by other virulent ASFV strains cannot be excluded, and future experi-
ments are planned to assess this interesting possibility.
It is remarkable that the activation of STING, after phosphorylation and dimerization,
involves trafficking from the ER through the Golgi compartment to perinuclear punc-
tuated structures, called microsomes (33, 34, 63). Significantly, STING appears in these
microsomes in most of the NH/P68-infected cells at 6 hpi, whereas at that time
postinfection with Armenia/07, STING is mainly found throughout the cytoplasm.
Transit of STING through the Golgi, prior to its translocation into microsomes, has been
shown to be a key event for STING activation, since STING undergoes posttranslational
modifications and interaction with molecules such as TBK1 (34, 64). Therefore, to further
assess the virulence mechanism of ASFV, we investigated whether the transit of STING
through the Golgi is blocked during Armenia/07 infection, as reported for other viruses
such as HSV-1 or human cytomegalovirus (57, 65). At very early times after both NH/P68
and Armenia/07 infection, STING traffics through the TGN in a similar manner than in
cGAMP-treated cells, while at 6 hpi this traffic is prevented in Armenia/07-infected cells
but not in NH/P68-infected cells, thus impairing the ability of STING to reach micro-
somes. These results suggest that at very early times of infection, STING is activated in
both NH/P68 and in Armenia/07 infected cells, but several hours later, the virulent ASFV
strain is able to block activation of STING.
The involvement of the cGAS-STING pathway in the control of IFN- production
during ASFV infection has not been described so far, and therefore the potential viral
candidate genes and/or the respective molecular mechanisms involved in blocking of
the cGAS-STING pathway are not yet known. From the results presented here, possible
viral gene candidates could be very early genes, such as products of the so-called
multigene families (66). In this regard, very recently, studies in human embryonic
kidney (HEK) cells, have postulated that the transfected DP96R gene of the Chinese
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virulent strain 2018/1 could have a role in the control of the cGAS-STING pathway (24).
However, these results should be discussed cautiously, since (i) HEK cells are not
susceptible to ASFV infection and (ii) these studies have not been performed in the
context of an active ASFV infection. In addition, the DP96R gene is present and identical
in both attenuated and virulent strains of the same genotype, such as NH/P68 and Ba71
(both genotype I) and has 98% identity between attenuated and virulent strains of
different genotypes, such as NH/P68 (genotype I) and Armenia/07 (genotype II).
Therefore, the experiments performed above with DP96R most likely do not explain the
differences in the cGAS-STING pathway modulation exerted by virulent and attenuated
ASFV strains.
Future in vitro and in vivo studies are necessary to elucidate the molecular mecha-
nisms of control of the cGAS-STING pathway by virulent strains of ASFV.
MATERIALS AND METHODS
Cell culture and virus infections. Porcine alveolar macrophages (PAM) were prepared by bron-
choalveolar lavage as described previously (67) and grown in Dulbecco modified Eagle medium (DMEM)
supplemented with 2 mM L-glutamine, 100 U/ml gentamicin, nonessential amino acids, and 10% porcine
serum. Cells were grown at 37°C in a 7% CO2 atmosphere saturated with water vapor. COS-1 cells (from
African green monkey kidney) were obtained from the American Type Culture Collection (ATCC) and
grown in DMEM supplemented with 2 mM L-glutamine, 100 U/ml gentamicin, nonessential amino acids,
and 2 to 5% fetal bovine serum (Invitrogen Life Technologies). The ASFV isolates Armenia/07 and NH/P68
were propagated on PAM. Briefly, subconfluent PAM cells were cultivated in p150 plates and infected
with ASFV at an MOI of 0.2 PFU/cell in DMEM–10% porcine serum. At 96 hpi, the cells were recovered and
centrifuged at 3,000 rpm for 15 min. The cell pellet was discarded. The supernatant containing the viruses
was clarified at 14,000 rpm for 6 h at 4°C, resuspended in medium, and stored at80°C. The viruses were
then titrated by plaque assay on COS-1 cells as previously described (64). Infection was performed after
ASFV adsorption at 37°C for 90 min, when the inoculum was removed, and fresh medium was added. The
cells were then incubated at 37°C for the times indicated (in hpi).
Antibodies and reagents. Polyclonal rabbit anti phospho-STING antibody (Ser366, catalog no.
85735), monoclonal rabbit anti phospho-IRF3 antibody (Ser396, catalog no. 4947), and monoclonal rabbit
anti phospho-TBK1/NAK antibody (Ser172, catalog no. 5483) were purchased from Cell Signaling.
Monoclonal mouse anti-IRF3 antibody (SL-12, sc-33641), anti-m-IgG secondary antibody (BP-HRP,
sc-516102), polyclonal goat anti actin antibody (I-19, sc-1616), and polyclonal goat anti -laminin (S-20)
were purchased from Santa Cruz Biotechnology. Polyclonal rabbit anti TMEM173/STING antibody (19851-
1-AP) was purchased from Proteintech. Polyclonal rabbit anti-histone H3 antibody (ab18521) was
acquired from Abcam. Antiserum 1262 was kindly provided by E. Tabarés; monoclonal mouse anti-p32
(S-1D8) was kindly provided by S.-Y. Sunwoo. Anti-rabbit/Alexa Fluor 488 and anti-mouse/Alexa Fluor 555
antibodies were purchased from Invitrogen. Anti-rabbit and anti-mouse immunoglobulin G coupled to
peroxidase and ECL Prime Western blotting detection reagent were acquired from Amersham Biosci-
ences. Monoclonal mouse anti--adaptin antibody (AP-1, A4200), anti-goat antibody G coupled to
peroxidase, and digitonin were acquired from Sigma-Aldrich.
Cellular fractionation. PAM were seeded in p60 plates (6  106 cells/plate) and mock or ASFV
infected (2 PFU/cell) for 8 h. The WCE, cytoplasmic fraction (S2), soluble nuclear fraction (S3), and
chromatin fraction (P3) were isolated as described previously (68). Briefly, cells were resuspended in
buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM
dithiothreitol [DTT], 0.1mM phenylmethylsulfonyl fluoride [PMSF], and protease and phosphatase inhib-
itors [Roche]) and Triton X-100 were added (separating a part for WCE), followed by incubation for 5 min
on ice. The nuclei were then centrifuged at 3,600 rpm 4 min at 4°C. The first supernatant (S1) was
centrifuged at 14,000 rpm 15 min at 4°C, and the second supernatant was stored (S2). The first pellet (P1)
was washed with buffer A and later was resuspended in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT,
0.1 mM PMSF, and protease and phosphatase inhibitors [Roche]), incubated 30 min on ice, and centri-
fuged at 4,000 rpm for 4 min at 4°C. The third supernatant (S3) was stored, and the third pellet (P3) was
washed with buffer B and finally resuspended in loading buffer.
cGAMP and Ru521 treatment. Cells were treated with a specific concentration of 2=3=-cGAMP
(Invivogen) or cGAS inhibitor Ru521 (Invivogen) in digitonin permeabilization buffer (50 mM HEPES [pH
7.0], 100 mM KCl, 85 mM sucrose, 3 mM MgCl2, 0.2% bovine serum albumin [BSA], 1 mM ATP, 0.1 mM
DTT, and 10 g/ml digitonin) (28). The cells were incubated for 30 min at 37°C, and then the cells were
washed with phosphate-buffered saline (PBS), and fresh medium or virus inoculation was added as
indicated. For the Ru521-treated samples, cells were incubated for 2 h with fresh DMEM before being
infected.
ELISA. PAM were seeded in 24-well plates (2 106 cells/well) and mock or ASFV infected (4 PFU/cell)
in DMEM–10% porcine serum. ASFV viral adsorption to cells was performed at 37°C for 90 min. The
inoculum was then removed, and 250 l of fresh DMEM medium without porcine serum was added. At
the indicated times postinfection, cell culture supernatants were collected and assayed for porcine IFN-
using a porcine IFN- ELISA kit (MyBioSource), as described by the manufacturer.
Immunofluorescence. PAM were grown on coverslips and treated or untreated with cGAMP
(20 g/ml) or mock or ASFV infected at the indicated MOI. At the indicated times postinfection (1 or 6
García-Belmonte et al. Journal of Virology
June 2019 Volume 93 Issue 12 e02298-18 jvi.asm.org 14
hpi) or 1 h after cGAMP treatment, the cells were fixed with 4% paraformaldehyde for 20 min at room
temperature, permeabilized with 0.2% Triton X-100 for 15 min, and blocked with PBS–5% BSA for 45 min.
The cells were stained with the primary antibodies anti-STING antibody (1/50) and anti--adaptin (AP1)
antibody (1/100) diluted in PBS–1% BSA for 1 h. The cells were then washed with PBS and incubated with
the fluorescence-conjugated secondary antibodies anti-rabbit/Alexa Fluor 488 (1/500) and anti-mouse/
Alexa Fluor 555 (1/500) diluted in PBS–1% BSA for 1 h. After a wash with PBS, the coverslips were
mounted with DAPI Fluoromount-G (SouthernBiotech). Images were acquired by using a CLSM LSM710
coupled to an inverted AxioObserver microscope (Zeiss) with a 63 oil immersion objective lens and
analyzed using ImageJ. Colocalization between STING and AP1 was quantified by calculating Mander’s
coefficient (M1) using the plugin JACoP (Just Another Colocalization Plugin; Fiji).
RT-qPCR assay. PAM were seeded in p60 plates (6 106 cells/plate) and mock or ASFV infected with
4 PFU/cell in DMEM–10% porcine serum. At 4, 8, or 16 hpi, the total RNA was harvested from cells using
an RNeasy kit (Qiagen). cDNA was synthesized using a NZY first-strand cDNA synthesis kit (NZYTech).
qPCR was performed using an CFX384 Touch real-time PCR detection system (Bio-Rad) with SYBR green
master mix (Promega). Gene expression levels were normalized to the housekeeping gene (18S rRNA),
and these values were then normalized to the mock-treated sample. The primers used were 5=-GGCCC
GAGGTTATCTAGAGTC-3= and 5=-TCAAAACCAACCCGGTCA-3= for porcine 18S rRNA detection, 5=-TCAGG
GCAAAGAGAGCCTTA-3= and 5=-GGCCATTTTGTCTGAATGCT-3= for porcine IFIT-1 detection, 5=-CAATGAA
AAAGAATGGGGAGA-3= and 5=-CCTTTCTTTGCTAATTGCTTTCA-3= for porcine CXCL10 detection, 5=-AAAA
ATGATAATGAAACCAATGAATG-3= and 5=-ATGAGGGCTCTTGCTCAAAC-3= for viral p32 detection, and 5=-
GTGGAACTTGATGGGCAGAT-3= and 5=-TTCCTCCTCCATGATTTCCTC-3= for porcine IFN- detection.
Western blot analysis. PAM were cultivated as indicated and mock or ASFV infected. At the specified
times postinfection, the cells were collected, washed with PBS, and lysed with radioimmunoprecipitation
assay (RIPA) buffer supplemented with protease and phosphatase inhibitors (Roche) for 30 min at 4°C,
sonicated, and centrifuged at 13,000 rpm for 10 min at 4°C. The supernatants were collected, and equal
amounts of protein per sample were used. Samples were resolved by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) and transferred to Immobilon-P membranes (Millipore). The
membranes were incubated with the following specific primary antibodies: anti-STING antibody (1/
1,000), anti-p-STING antibody (1/1,000), anti-IRF3 antibody (1/200), anti-p-IRF3 antibody (1/1,000), anti-
p-TBK1 antibody (1/1,000), anti-actin antibody (1/5,000), anti--laminin antibody (1/1,000), anti-histone 3
antibody (1/2,000), anti-p32 antibody (1/5,000), and anti-1262 antibody (1/1,000) diluted in Tris-buffered
saline (TBS) supplemented with 1% milk. Membranes were washed three times with TBS and exposed 1 h
to specific peroxidase-conjugated secondary antibodies: anti-rabbit and anti-mouse immunoglobulin G
coupled to peroxidase (1/5,000 and 1/2,000, respectively) from Amersham Biosciences and anti-m-IgG
secondary antibody (1/1,000) from Santa Cruz Biotechnology. Chemiluminescence detection was per-
formed using ECL Prime (Amersham Biosciences).
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